Basic information Safety Supplier Related

1-(3,4-DICHLORO-PHENYL)-3-AZA-BICYCLO[3.1.0]HEXANE HCL

Basic information Safety Supplier Related

1-(3,4-DICHLORO-PHENYL)-3-AZA-BICYCLO[3.1.0]HEXANE HCL Basic information

Product Name:
1-(3,4-DICHLORO-PHENYL)-3-AZA-BICYCLO[3.1.0]HEXANE HCL
Synonyms:
  • 1-(3,4-DICHLORO-PHENYL)-3-AZA-BICYCLO[3.1.0]HEXANE HCL
  • 1-(3,4-Dichloro-phenyl)-3-aza-bicyclo[3.1.0]hexane hydrochloride
  • 1-(3,4-Dichloro-phenyl)-3-aza-bicyclo[3.1.0]hexane hychloride
  • DOV216303 HCl
  • CL 216303
  • CL216303
  • CL-216303
  • CL-216303 HCl
CAS:
86215-36-3
MF:
C11H12Cl3N
MW:
264.58
Product Categories:
  • pharmacetical
Mol File:
86215-36-3.mol
More
Less

1-(3,4-DICHLORO-PHENYL)-3-AZA-BICYCLO[3.1.0]HEXANE HCL Chemical Properties

storage temp. 
-20°C
solubility 
DMSO: ≥10mg/mL
form 
powder
color 
white to beige
CAS DataBase Reference
86215-36-3
More
Less

Safety Information

Hazard Codes 
T
Risk Statements 
25-36
Safety Statements 
26-45
RIDADR 
UN 2811 6.1 / PGIII
WGK Germany 
3
More
Less

1-(3,4-DICHLORO-PHENYL)-3-AZA-BICYCLO[3.1.0]HEXANE HCL Usage And Synthesis

Uses

DOV-216,303 is an antidepressant compound. DOV-216,303 inhibits the reuptake of norepinephrine (NE), serotonin (5‐HT), and dopamine (DA), with IC50 values of 14 nM, 20 nM and 78 nM for hSERT, hNET and hDAT, respectively. DOV-216,303 increases monoamine release in the prefrontal cortex of olfactory bulbectomized (OBX) rats[1][2][3].

Biological Activity

Triple reuptake inhibitor (TRI); serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI); IC50 values of ~20, 14, and 78 nM, respectively.

References

[1] Skolnick P, et al. Preclinical and clinical pharmacology of DOV 216,303, a "triple" reuptake inhibitor. CNS Drug Rev. 2006 Summer;12(2):123-34. DOI:10.1111/j.1527-3458.2006.00123.x
[2] Shao L, et al. Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor. Bioorg Med Chem Lett. 2011 Mar 1;21(5):1438-41. DOI:10.1016/j.bmcl.2011.01.016
[3] Prins J, et al. The putative antidepressant DOV 216,303, a triple reuptake inhibitor, increases monoamine release in the prefrontal cortex of olfactory bulbectomized rats. Eur J Pharmacol. 2010 May 10;633(1-3):55-61. DOI:10.1095/biolreprod44.3.561

1-(3,4-DICHLORO-PHENYL)-3-AZA-BICYCLO[3.1.0]HEXANE HCLSupplier

Aikon International Limited
Tel
025-66061636 18013972705
Email
qqyang@aikonchem.com
Bejing Famous Pharmaceutical Technology Co., Ltd.
Tel
13331045123
Email
2559355526@qq.com
TargetMol Chemicals Inc.
Tel
+1-781-999-5354; +17819995354
Email
marketing@targetmol.com
CHENGDU JINMAIRUI BIO-TECHNOLOGY CO.LTD
Tel
028-83133020 18280298385
Email
1223808415@qq.com
TargetMol Chemicals Inc.
Tel
4008200310
Email
marketing@tsbiochem.com